Ocular surface disease in patients with moderate-to-severe atopic dermatitis and the effect of new systemic treatments

Ocular surface disease in patients with moderate-to-severe atopic dermatitis and the effect of new systemic treatments (e.g. biologicals and JAK-inhibitors).

Contact 
Nienke Veldhuis